![Leaf Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 69 $ am 30.09.2026
Leaf Huang is the founder of Lipella Pharmaceuticals, Inc. which was founded in 2005.
He held the title of Director from 2005 to 2013.
Dr. Huang is also the founder of LipoGenics, Inc., RGene Therapeutics, Inc., OncoTrap, Inc. Dr. Huang earned a doctorate degree from Michigan State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2025 | 69 443 ( 1,5 % ) | 69 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
LipoGenics, Inc.
 LipoGenics, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dietary supplements | Gründer | 19.02.2010 |
RGene Therapeutics, Inc.
 RGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Research and design of gene therapy | Gründer | 19.02.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
OncoTrap, Inc.
 OncoTrap, Inc. Miscellaneous Commercial ServicesCommercial Services Develops the medicine that induces or potentiates the immune response as a means to eradicate tumor burden | Gründer | - |
| LIPELLA PHARMACEUTICALS INC. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Lipella Pharmaceuticals, Inc.
 Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LipoGenics, Inc.
LipoGenics, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dietary supplements | Consumer Non-Durables |
RGene Therapeutics, Inc.
RGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Research and design of gene therapy | Commercial Services |
OncoTrap, Inc.
OncoTrap, Inc. Miscellaneous Commercial ServicesCommercial Services Develops the medicine that induces or potentiates the immune response as a means to eradicate tumor burden | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
